de Jong Margriet F C, Beishuizen Albertus, Spijkstra Jan-Jaap, Girbes Armand R J, Groeneveld A B Johan
Intensive Care and Institute for Cardiovascular Research, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands.
Clin Endocrinol (Oxf). 2007 May;66(5):732-9. doi: 10.1111/j.1365-2265.2007.02814.x. Epub 2007 Mar 23.
To determine whether relative adrenal insufficiency (RAI) can be identified in nonseptic hypotensive patients in the intensive care unit (ICU).
Retrospective study in a medical-surgical ICU of a university hospital.
One hundred and seventy-two nonseptic ICU patients (51% after trauma or surgery), who underwent a short 250 microg ACTH test because of > 6 h hypotension or vasopressor/inotropic therapy.
On the test day, the Simplified Acute Physiology Score II (SAPS II) and Sequential Organ Failure Assessment (SOFA) score were calculated to estimate disease severity. The ICU mortality until day 28 was recorded. Best discriminative levels of baseline cortisol, increases and peaks were established using receiver operating characteristic curves. These and corticosteroid treatment (in n = 112, 65%), among other variables, were examined by multiple logistic regression and Cox proportional hazard regression analyses to find independent predictors of ICU mortality until day 28.
ICU mortality until day 28 was 23%. Nonsurvivors had higher SAPS II and SOFA scores. Baseline cortisol levels correlated directly with albumin levels and SAPS II. In the multivariate analyses, a cortisol baseline > 475 nmol/l and cortisol increase < 200 nmol/l predicted mortality, largely dependent on disease severity but independent of albumin levels. Corticosteroid (hydrocortisone) treatment was not associated with an improved outcome, regardless of the ACTH test results.
In nonseptic hypotensive ICU patients, a low cortisol/ACTH response and treatment with corticosteroids do not contribute to mortality prediction by severity of disease. The data thus argue against RAI identifiable by cortisol/ACTH testing and necessitating corticosteroid substitution treatment in these patients.
确定在重症监护病房(ICU)的非感染性低血压患者中是否能识别出相对肾上腺皮质功能不全(RAI)。
在一所大学医院的内科-外科ICU进行的回顾性研究。
172例非感染性ICU患者(51%为创伤或手术后患者),因低血压持续超过6小时或接受血管升压药/正性肌力药物治疗而接受了短程250微克促肾上腺皮质激素(ACTH)试验。
在试验当天,计算简化急性生理学评分II(SAPS II)和序贯器官衰竭评估(SOFA)评分以评估疾病严重程度。记录至第28天的ICU死亡率。使用受试者工作特征曲线确定基线皮质醇、升高值和峰值的最佳鉴别水平。通过多因素逻辑回归和Cox比例风险回归分析对这些指标以及皮质类固醇治疗(n = 112,65%)等变量进行检查,以找出至第28天ICU死亡率的独立预测因素。
至第28天的ICU死亡率为23%。非幸存者的SAPS II和SOFA评分更高。基线皮质醇水平与白蛋白水平和SAPS II直接相关。在多变量分析中,皮质醇基线> 475纳摩尔/升且皮质醇升高< 200纳摩尔/升可预测死亡率,这在很大程度上取决于疾病严重程度,但与白蛋白水平无关。无论ACTH试验结果如何,皮质类固醇(氢化可的松)治疗均与改善预后无关。
在非感染性低血压的ICU患者中,低皮质醇/ACTH反应和皮质类固醇治疗无助于根据疾病严重程度预测死亡率。因此,这些数据表明反对通过皮质醇/ACTH检测识别RAI并在这些患者中进行皮质类固醇替代治疗。